Distinct modifications in Kv2.1 channel via chemokine receptor CXCR4 regulate neuronal survival-death dynamics

J Neurosci. 2012 Dec 5;32(49):17725-39. doi: 10.1523/JNEUROSCI.3029-12.2012.

Abstract

The chemokine stromal cell-derived factor-1α (SDF-1α) has multiple effects on neuronal activity, survival, and death under conditions that generate a proinflammatory microenvironment within the brain, via signaling through C-X-C-type chemokine receptor 4 (CXCR4), although the underlying cellular/molecular mechanisms are unclear. Using rat hippocampal neurons, we investigated distinct modifications in the voltage-gated K⁺ (Kv) channel Kv2.1 in response to short- and long-term SDF-1α/CXCR4-mediated signaling as an underlying mechanism for CXCR4-dependent regulation of neuronal survival and death. Acute exposure of neurons to SDF-1α led to dynamic dephosphorylation and altered localization of Kv2.1 channel, resulting in enhanced voltage-dependent activation of Kv2.1-based delayed-rectifier Kv currents (I(DR)). These changes were dependent on CXCR4- and/or NMDA receptor-mediated activation of calcineurin and provide neuroprotection. However, prolonged SDF-1α treatment leads to CXCR4-mediated activation of p38 mitogen-activated protein kinase, resulting in phosphorylation of Kv2.1 at S800 and enhanced surface trafficking of the channel protein, resulting in increased I(DR)/Kv2.1 current density. This, in combination with sustained dephosphorylation-induced enhancement of the voltage-dependent activation of I(DR)/Kv2.1, predisposed neurons to excessive K⁺ efflux, a vital step for the neuronal apoptotic program. Such apoptotic death was dependent on CXCR4 and Kv2.1 function and was absent in cells expressing the Kv2.1-S800A mutant channel. Furthermore, similar modifications in Kv2.1 and CXCR4/Kv2.1-dependent apoptosis were observed following treatment of neurons with the human immunodeficiency virus-1 (HIV-1) glycoprotein gp120. Therefore, distinct modifications in Kv2.1 in response to short- and long-term CXCR4-mediated signaling could provide a basis for neuroprotection or apoptosis in neuropathologies, such as neuroinflammation, stroke, brain tumors, and HIV-associated neurodegeneration.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Apoptosis / physiology*
  • Calcineurin / physiology
  • Calcineurin Inhibitors
  • Cell Death / physiology
  • Cell Survival / physiology
  • Chemokine CXCL12 / pharmacology
  • Chemokine CXCL12 / physiology*
  • Drug Interactions
  • Female
  • HEK293 Cells
  • HIV Envelope Protein gp120 / pharmacology
  • Hippocampus / drug effects
  • Hippocampus / physiology
  • Humans
  • Male
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology
  • Mutant Proteins / physiology
  • Neurons / metabolism
  • Neurons / physiology
  • Phosphorylation
  • Primary Cell Culture
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, CXCR4 / agonists
  • Receptors, CXCR4 / physiology*
  • Shab Potassium Channels / genetics
  • Shab Potassium Channels / metabolism*
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Tacrolimus / pharmacology
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Calcineurin Inhibitors
  • Chemokine CXCL12
  • Cxcr4 protein, rat
  • HIV Envelope Protein gp120
  • Kcnb1 protein, rat
  • Mutant Proteins
  • Receptors, CXCR4
  • Shab Potassium Channels
  • gp120 protein, Human immunodeficiency virus 1
  • p38 Mitogen-Activated Protein Kinases
  • Calcineurin
  • Tacrolimus